Canine Transforming Growth Factor-ß Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-ß1 Immunosuppression.

Takeuchi, Hiroto; Konnai, Satoru; Maekawa, Naoya; Takagi, Satoshi; Ohta, Hiroshi; Sasaki, Noboru; Kim, Sangho; Okagawa, Tomohiro; Suzuki, Yasuhiko; Murata, Shiro; Ohashi, Kazuhiko

Takeuchi, Hiroto; Konnai, Satoru; Maekawa, Naoya; Takagi, Satoshi; Ohta, Hiroshi; Sasaki, Noboru; Kim, Sangho; Okagawa, Tomohiro; Suzuki, Yasuhiko; Murata, Shiro; Ohashi, Kazuhiko.

Afiliação

Takeuchi H; Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Konnai S; Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Maekawa N; Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Takagi S; Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Ohta H; Department of Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Sasaki N; Department of Veterinary Surgery, School of Veterinary Medicine, Azabu University, Sagamihara, Japan.
Kim S; Department of Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Okagawa T; Department of Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Suzuki Y; Department of Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Murata S; Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Ohashi K; Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.